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ScienceDirectGenome architecture plays a critical role in regulating the
expression of genes that are essential for nervous system
development. During neuronal differentiation, spatially and
temporally regulated transcription allows neuronal migration,
the growth of dendrites and axons, and at later stages, synaptic
formation and the establishment of neuronal circuitry. Genome
topology and relocation of gene loci within the nucleus are now
regarded as key factors that contribute to transcriptional
regulation. Here, we review recent work supporting the
hypothesis that the dynamic organization of chromatin within
the nucleus impacts gene activation in response to extrinsic
signalling and during neuronal differentiation. The
consequences of disruption of the genome architecture on
neuronal health will be also discussed.
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Introduction
Development and function of the mammalian central
nervous system (CNS) pose a great challenge for gene
regulation. A fairly homogenous population of neuronal
precursors gives rise to a dazzling array of cell types that
include neurons, oligodendrocytes, astrocytes, microglia
and endothelial cells [1]. Moreover, single cell sequenc-
ing experiments have revealed an increasing number of
neuronal types with molecularly distinct features [2].
This multitude of neuronal and non-neuronal cell types
is generated through careful control of cell proliferation,
migration, and terminal differentiation. The CNS largely
retains plasticity throughout the life of the organism and
this ability to adapt to the external environment is nec-
essary for learning, and ultimately survival.Current Opinion in Neurobiology 2019, 59:16–25 In all eukaryotic cells, the genome is heavily compacted
to fit inside the nucleus. Despite this compression, genes
must remain accessible for transcription, DNA replication
and other nuclear processes. In the nucleus, chromatin is
highly organized within the three-dimensional (3D)
space, allowing tight control of gene expression. Genome
conformation is regulated at multiple levels, from the
wrapping of DNA around histones to form nucleosomes,
to epigenetic modifications of DNA and histones, and
ATP-dependent histone sliding and exchange. In addi-
tion, a key role is played by the formation of higher order
domains, and by the movement of genomic regions in
relation to nuclear landmarks. Interplay within and
between these levels of regulation allows precise gene
regulation.
In this review, we will describe recent work demonstrat-
ing how genome topology and nuclear positioning influ-
ence gene transcription in neurons. We will illustrate the
unforgiving nature of nuclear structure deregulation by
describing neurological diseases resulting from mutations
affecting genome architecture.
The nuclear lamina is a repressive
compartment for transcription
The radial arrangement of the genome within the nucleus
is highly ordered. The nuclear periphery is enriched in
heterochromatin and is generally associated with gene-
poor or transcriptionally silent regions of the genome; it is,
therefore, considered a compartment that represses tran-
scription. During neuronal development, certain genes
move away from the lamina toward the nuclear interior,
and this event is concomitant with transcriptional activa-
tion [3–5] (Figure 1a). Similarly, in the adult brain, Bdnf
activation by kainate-induced seizures is accompanied by
movement of the Bdnf gene away from the nuclear
periphery [6]. Such movement may relocate genes away
from a repressive environment, or toward sites rich in
transcriptional apparatus. In embryonic cortical neurons
for example, activity-dependent genes such as cFos and
Gadd45b relocate to RNA polymerase II (RNAPII) foci in
response to depolarization [7,8]
Lamina-associated domains (LADs) are large genomic
regions that localize at the nuclear lamina and guide the
spatial organization of the interphase nucleus [9]. LADs
are predominantly gene-poor and contain silent genes
bearing repressive histone modifications. Detailed map-
ping of LADs in mouse embryonic stem cells (ESCs),
neuronal progenitor cells (NPCs) and astrocytes revealedwww.sciencedirect.com
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Neuronal differentiation is marked by genome architecture changes.
There are marked differences at all hierarchical levels of genome architecture between pluripotent embryonic stem cells (ESCs), multipotent neural
progenitor cells (NPCs) and terminally differentiated cortical neurons (CNs). (a) Following activation, many neuronal genes move radially toward the
center and away from the repressive nuclear periphery. It should be noted that dissociation from the lamina often reflects the acquisition of
transcriptional competence rather than gene activation. (b) At TAD level, changes in the boundaries of some TADs, depicted as triangles, lead to
the formation of neural specific boundaries. Increasing colour intensity represents regions that show more frequent interaction. (c) At the finest
level, dynamic changes in sub-TAD looping and cell type specific factors induce local loop formation.that in most cases, dissociation from the nuclear lamina
protein LaminB1 resulted in the transcription of genes
involved in neuronal and astrocyte specification [5]. Some
LADs are constitutive, but hundreds of genes change
their lamina interaction during differentiation. Impor-
tantly, not only have correlations between radial location
and gene expression been observed in a variety of cell
types but tethering of genes to the lamina was found towww.sciencedirect.com induce gene silencing [10]. Conversely, forced activation
of endogenous genes within a LAD was sufficient to
relocate the region to the nuclear interior [11]. Interest-
ingly, during the early stages of neuronal differentiation, a
substantial group of genes detached from the lamina but
remained inactive [5]. These findings suggest that while
movement away from the lamina is often necessary for
triggering transcription, it is not capable of inducing geneCurrent Opinion in Neurobiology 2019, 59:16–25
18 Neural epigeneticsactivation per se (Figure 1a). Nonetheless, these genes
were more prone to transcriptional activation at later
differentiation stages [5], indicating that release from
the lamina may prime them for rapid expression when
additional extrinsic signals come into play. This is in
accordance with data showing that decondensation of
endogenous genes within a LAD was sufficient to relocate
the region to the nuclear interior, without affecting tran-
scription [11].
A striking example of how nuclear geometry can be
regulated in the nervous system is provided by the
dramatic folding of the nuclear membrane observed in
hippocampal neurons [12]. The nuclear infoldings were
dynamic, and increased in number following synaptic
activation, leading to an increase in surface area of the
transcriptionally repressive lamina. These nuclear mem-
brane invaginations may facilitate the relay of calcium
signals to the nucleus by generating smaller functional
compartments, and may affect transcriptional regulation.
Quiescent neural stem cells also develop nuclear enve-
lope invaginations, which may contain telomeres and
other heterochromatin domains [13]. Although it is
unclear whether these invaginations are functionally
related to the infoldings described in neurons, they also
affect the surface area of a transcriptionally repressive
compartment and may lead to the existence of signaling
microdomains.
Role of the nuclear lamina in the pathogenesis of
neurological disorders
The protein components of the lamina are critical for its
regulatory function (Box 1), and disruption of them may
cause neurological disease. LaminB1 is required for brain
development [14,15], for dendritogenesis in cortical neu-
rons [16], and for the regulation of gene expression duringBox 1 Constituents of the lamina
The major structural components of the nuclear lamina are the A-
type Lamins A and C that are alternatively spliced from the LMNA
gene, and the B-type Lamins B1 and B2. Expression of LaminB1 and
the LaminB receptor decreases during neuronal development [23].
Interestingly, lamins are not required for the interaction of LADs with
the nuclear envelope but are necessary for tethering heterochromatin
at the periphery [61]. The lamina is punctuated by nuclear pore
complexes, large structures that mediate molecular trafficking
between the nucleus and cytoplasm [62]. Although lamina associa-
tion is generally negative for transcription, this is not always the case
at nuclear pores. In NPCs, the transcription factor Sox2 and
Nucleoporin153 (Nup153) bind to shared target genes [63], providing
a striking example of how interaction of a lineage-specific tran-
scription factor with the nuclear pore complex may regulate gene
expression. The interaction between Nup153 and Sox2 is essential
for the maintenance of NPCs, and Nup153 expression declined when
NPCs differentiated into neurons and astrocytes. Interestingly, while
the interaction of Nup153 with gene promoters correlated with
transcriptional activation, binding at gene ends resulted in repres-
sion, suggesting that nuclear pores play a complex role in regulating
transcriptional output.
Current Opinion in Neurobiology 2019, 59:16–25 olfactory neuron differentiation [17]. Mice lacking the
LaminB1 paralog, LaminB2, exhibit cortical develop-
ment defects [14,15]. Importantly, loss of function muta-
tions of LMNB1 in humans result in neural tube defects
[18], whereas mutations of the LMNA gene gives rise to a
group of disorders known as the laminopathies [19]. In
addition to the well-known premature ageing disease
Hutchinson–Gilford progeria syndrome, laminopathies
include more than 15 distinct diseases characterized by
muscular, metabolic and neurological symptoms.
Although the mechanisms are undoubtedly complex
and remain to be fully elucidated, genes and indeed
entire chromosomes have been shown to change radial
nuclear position, implying that transcriptional regulation
is likely an important facet of the disease (Figure 3a).
Chromosomes are organized into
topologically associating domains (TADs)
The genome is arranged in self-interacting genomic
regions known as topologically associating domains
(TADs) [20,21]. DNA sequences within a TAD interact
more frequently with each other than with regions located
outside. TAD boundaries function as transcriptional insu-
lators. Chromosome conformation capture technologies,
which use ligation to link regions that are close together in
3D space, have allowed identification of genomic contacts
on a large scale. Importantly, the existence of TADs was
recently confirmed genome-wide using a ligation-inde-
pendent method that relies instead on genome amplifi-
cation and DNA sequencing from nuclei dissected into
ultrathin sections [22]. TADs have been identified in all
cell types studied, including mouse and human brain
[23,24]. TAD organization is generally stable, and
some TAD boundaries are conserved across differentia-
tion stages, cell types and even between species [21].
Multiple lines of evidence indicate that TADs are formed
by loading of cohesin onto the genome, which uses energy
derived from ATP hydrolysis to spool the DNA through
its ring-like structure, forming a TAD [25] (Figure 2).
Extrusion stops when cohesin encounters CTCF
(CCCTC-binding factor) bound to the DNA, resulting
in the majority of TAD boundaries containing both
CTCF and cohesin.
A recent study performed ultradeep mapping of genome
interactions in mouse ESCs, NPCs and cortical neurons
(CNs) differentiated in vitro, as well as NPCs and CNs
purified from embryonic cortex [23]. The authors found
that during neuronal differentiation, a global reorganiza-
tion of chromatin takes place (Figure 1b). Although many
TAD boundaries remain unchanged, in general TADs
become fewer and larger, average intra-TAD contacts
become stronger and average inter-TAD contacts are
depleted. Importantly, formation of new TAD bound-
aries was observed close to developmentally regulated
genes as they became transcriptionally activated during
neuronal differentiation. However, forced activation of awww.sciencedirect.com
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Sub-TAD looping events.
Intra-TAD contacts are dynamic and cell type specific. Active genes show intra-gene interactions between promoter, coding region and 30 end,
which may regulate splicing or RNAPII recycling. Loops are also formed between active promoters and their cell type-specific enhancers. Finally,
interactions may occur between different active, but not inactive, genes, and correlate with the levels of gene expression.silent genomic region was insufficient to create a TAD
boundary. This suggests that transcription alone is not
sufficient to induce the structural changes associated with
boundary formation, but rather the formation of new
TAD boundaries during neuronal development may be
permissive or instructive for the expression of specific
genes.
Regulation of TAD organization during neuronal
development
Bonev et al. showed three distinct classes of TAD bound-
aries in NPCs and CNs: first, boundaries characterized by
the presence of CTCF and cohesin; second, CTCF-
negative, cohesin-positive boundaries that are close to
active gene promoters; and finally, boundaries without
active marks of transcription that are enriched for repeat
elements [23]. Below we will discuss the major players
in TAD regulation and their role in neuronal gene
regulation.
CTCF
CTCF is a DNA-binding protein that plays a critical role in
determining looping interactions at various levels of the
architectural hierarchy [26]. CTCF can regulate both inter-
chromosomal and intra-chromosomal interactions and iswww.sciencedirect.com integral in establishing TAD boundaries and sub-TAD
looping. A recent study used an acute depletion system
to remove CTCF from murine ESCs, NPCs and astrocytes
[27]. Dramatic loss of looping and insulation at TAD
boundaries was observed upon CTCF depletion, which
caused the merging of neighboring TADs and the forma-
tion of ectopic contacts across the original TAD borders.
These changes were coincident with transcriptional dysre-
gulation, although the defects were less severe in astrocytes
than ESCs or NPCs, suggesting a less prominent role for
CTCF in terminally differentiated cells. This is in keeping
with an increasing proportion of CTCF-negative borders
during neuronal differentiation [23]. Interestingly, TAD
insulation was re-established upon restoration of CTCF
levels in ESCs and NPCs, but not in resting astrocytes,
indicating that passage through the cell cycle may be
indispensable for restoring TAD boundaries [27].
In mice, increasing evidence indicates that CTCF influ-
ences theexpressionofneuronalgenes[28,29,30], including
the protocadherin genes, whose stochastic variation in
expression levels generates neuronal diversity [28,29]. In
the developing cortex, CTCF regulates NPC differentiation
and survival [31], and at later stages, dendritic arborization
and spine development [28]. In cortical interneurons, CTCFCurrent Opinion in Neurobiology 2019, 59:16–25
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Mechanisms of disease caused by alteration of genome topology.
Disruption of chromosome organization is associated with the transcriptional dysregulation observed in many neurological disorders. (a) ‘
Organizer’ genes encode proteins with roles in configuring the genome within the 3D nucleus. Mutation in ‘organizer’ genes causes loss of these
important proteins, and thereby dramatic downstream effects on gene expression. Examples include mutations in cohesin, YY1, CTCF, and
Lamins A and B1. (b) Mutations in TAD boundaries can cause neighboring TADs to merge, creating ectopic contacts such as enhancer–promoter
(E–P) loops that induce inappropriate gene activation. Examples include TAD border deletion leading to aberrant activation of LMNB1 and FOXG1.
(c) Mutations can prevent sub-TAD interactions such as E–P or active gene looping, abrogating gene activation.regulates the expression of genes involved in fate determi-
nation, and mutations of the CTCF gene lead to defects in
cell identity and neuronal migration [30]. Loss of CTCF in
the hippocampus is associated with impaired long-term
potentiation, reduced dendritic spine density, and defects
in spatial and fear memory [29]. As well as finding many
deregulated genes in the hippocampus of CTCF-knockout
mice, including protocadherin and learning-related genes,
the authors found a significant lack of upregulation of Bdnf
and Arc genes in response to fear conditioning. The absence
of induced Bdnf and Arc expression was associated with
disruption of the genome architecture surrounding the gene
loci. This suggests that stimuli-responsive gene expression is
affected by CTCF-regulated genome architecture, as well as
developmentally regulated gene programs.
Cohesin
Cohesin is a ring-like multiprotein complex initially
described as part of the complex that holds sister chro-
matids together during anaphase and later found to have
an additional role in genome architecture [32]. Cohesin isCurrent Opinion in Neurobiology 2019, 59:16–25 critical for genome looping in neural stem cells differen-
tiated into astrocytes in vitro [33]. Loss of cohesin causes
loss of TAD insulation, increasing inter-TAD interactions
and resulting in widespread transcriptional dysregulation
[33]. The transcriptional changes resulting from loss of
cohesin may cause a number of downstream effects,
depending on the cell type. The nervous system may
be particularly sensitive to cohesin-mediated transcrip-
tion changes as mutation of cohesin in mice induces
behavioral defects, possibly due to transcriptional dysre-
gulation of genes necessary for dendrite and synapse
development [34,35]. Importantly, mutations of the cohe-
sin pathway in humans cause Cornelia de Lange syn-
drome, a severe developmental disorder that manifests
with neurological symptoms, including psychomotor
delay and intellectual disability [36].
Topoisomerase IIb (TOP2B)
TOP2B is a member of the DNA topoisomerase family
responsible for relaxing the DNA supercoils that change
DNA topology, and often co-occupies TAD boundarieswww.sciencedirect.com
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that TOP2B plays an essential role in neuronal develop-
ment, as deletion of the gene in mice induced profound
defects in motor and sensory neuron innervation [38]. In
cortical neurons, TOP2B and CTCF are found in a
complex bound to many neuronal genes, in keeping with
the idea that TOP2B may regulate genome structure in
the brain [39] and that this may explain some of the
effects of TOP2B loss on neuronal development. An
intriguing finding of this study is that TOP2B promotes
expression of activity regulated genes, at least in part, by
causing DNA double strand breaks in response to neuro-
nal activity, suggesting that relieving topological con-
straint may be critical for gene expression.
Diseases caused by mutations in TAD boundaries
TAD boundaries insulate genomic regions from each
other, and, therefore, perturbation of TAD boundaries
leads to inappropriate interactions between chromatin
regions, including aberrant enhancer–promoter looping
(Figure 3b). Recent technological advances have allowed
sequencing of patient samples to go beyond the exome
and identify more variants in the non-coding portion of
the genome. As a result, it is increasingly recognized that
mutations in TAD borders contribute significantly to both
Mendelian heritable disorders and complex multifactorial
diseases.
One example is provided by Fragile X syndrome, a
disease marked by severe cognitive defects that is caused
by a repeat expansion in the FMR1 gene. FMR1 encodes
Fragile X Mental Retardation Protein (FMRP), a transla-
tional repressor essential for normal cognitive develop-
ment [40]. An interesting recent study indicated that the
repeat expansion within FMR1 interferes with CTCF
binding sites, disrupting a TAD border and inhibiting
FMR1 expression [41]. The authors hypothesize that
TAD disruption alters looping of the FMR1 promoter
to enhancers. Importantly, this disease mechanism may
extend to other neurological disorders, as the authors
found a striking correlation between disease-associated
DNA repeats and TAD boundaries, at boundaries with
high CpG island density [41]. A case study of the rare
neurological disorder Autosomal Dominant adult-onset
demyelinating LeukoDystrophy (ADLD) provides
another example of how nuclear architecture may influ-
ence gene regulation [42]. The deletion observed in
ADLD patients eliminates a TAD boundary, allowing
an enhancer to contact the LMNB1 gene, amplifying its
expression. LMNB1 encodes the LaminB1 protein that is
an integral part of the nuclear lamina, itself a repressive
compartment for transcription (Box 1). Therefore, this
example highlights two points at which gene regulation
through nuclear architecture can be manipulated in dis-
ease. LMNB1 overexpression causes progressive CNS
demyelination, autonomic dysfunction, ataxia and cogni-
tive impairment.www.sciencedirect.com A survey of 922 deletion sites found in the DECIPHER
clinical genome database further revealed that many
disease-associated deletions overlap TAD boundaries
[43]. Analysis of enhancer usage and gene functions
suggested that part of the disease phenotypes could be
attributed to the adoption of new enhancers following
boundary disruption, and consequent transcriptional
changes. The phenotype of the disorders in this survey
is complex and often involves several organs; however
intellectual disability, along with congenital abnormali-
ties, is one of the most common symptoms [43]. This
suggests that the developing brain may be more sensitive
to epigenetic insults, compared to other tissues. In one
interesting example from this study, deletion of a bound-
ary brings an ectopic foetal brain enhancer into the
regulatory domain of FOXG1 [43]. FOXG1 encodes a
transcription factor that is expressed in the developing
nervous system from the earliest stages and is critical for
regulating multiple important processes including dorso-
ventral patterning, neural precursor proliferation, neuro-
nal differentiation, and neuronal cell fate [44]. Patients
with the boundary deletion exhibit neurodevelopmental
defects, with intellectual disability, developmental delay,
and postnatal microcephaly [43], similar to that caused by
mutations in FOXG1 itself [45]. However, a recent study
suggests that the deletion causes loss of FOXG1 regula-
tory elements that are of more significance in the patient
phenotype than the TAD boundary deletion [46].
Dynamic looping generates sub-TADs
Within the TADs themselves, highly variable restructur-
ing of the chromatin architecture creates sub-TAD loops,
which may link genes to their enhancers or to other co-
regulated genes (Figure 2). Sub-TAD looping is tightly
controlled to ensure correct spatiotemporal gene regula-
tion, and varies markedly between cell types and devel-
opmental stages. Although CTCF is implicated in the
formation and maintenance of sub-TADs, other mecha-
nisms are also involved.
During neuronal differentiation, average intra-TAD con-
tacts become stronger [23]. Interactions independent of
CTCF binding were detected between promoters of
active genes at all developmental stages and correlated
with gene expression. Surprisingly, the authors identified
very long-range (>30 MB) looping events between acti-
vated genes in ESCs, NPCs and CNs. These interactions
span TADs, and even occur between genes on different
chromosomes. Contact enrichment correlated with the
number of exons, RNA splicing events and gene tran-
scription levels. Contacts between transcribed genes have
also been described in astrocytes, where the astrocyte-
specific gene Gfap has been found to associate with a
number of other expressed genes [47]. One recent excit-
ing discovery was that during olfactory neuron differenti-
ation, olfactory receptor genes aggregate with each other
and with their enhancers [48]. In progenitor cells thisCurrent Opinion in Neurobiology 2019, 59:16–25
22 Neural epigeneticsclustering seems to be repressive for transcription. How-
ever, in mature olfactory sensory neurons, the transcribed
olfactory receptor gene separates from the repressive
cluster and forms a separate hub together with its enhan-
cers. Thus, long range trans interactions create both an
activating structure for a single gene, and a repressive
structure to prevent expression of more than one olfactory
receptor gene per cell [48].
At a finer level, interactions were observed between the
promoter and the entire transcribed region of expressed
genes, as well as the termination site [23] (Figure 2). Such
intra-gene contacts may be required for RNA splicing and
RNAPII recycling. Looping events that allowed the estab-
lishment of enhancer–promoter contacts were primarily
identified within TADs and, as for contacts between pro-
moters, were predominantly independent of CTCF bind-
ing. As perhaps expected, enhancer–promoter contacts
correlatedwith transcriptional activation, further indicating
the impact of highly dynamic changes of chromatin archi-
tecture on gene expression during neuronal differentiation.
Regulation of sub-TAD looping during neuronal
development
Proteins implicated in establishing or stabilizing
enhancer–promoter loops include CTCF, YY1 [49,50],
RNAPII [51], HNRNPU [52], the chromatin remodeler
SMARCA4 [53,54], and the Mediator complex [55]. Neu-
ral-specific transcription factors have also recently been
implicated in organizing genome topology [23,48].
Although CTCF does regulate sub-TAD looping, its role
diminishes during neuronal differentiation, concomitant
with a decrease in the number of CTCF binding sites
across the genome [50]. Similarly, in the adult cortex,
cerebellum and olfactory bulb, fewer CTCF binding sites
were found when compared to the embryonic brain.
Decreased CTCF binding correlated with lower levels
of CTCF expression [29,50], which also varied between
cell types within the CNS [29]. Interestingly, the devel-
opmental decrease of global CTCF and of CTCF binding
was uniquely observed in the neural lineage [50]. ESCs
and NPCs showed a similar number of looping events
despite reduced CTCF occupancy in NPCs, demonstrat-
ing that a higher percentage of NPC-only loops were not
anchored by CTCF [50]. This indicates that other pro-
teins contribute to maintaining chromatin architecture in
differentiated neurons.
Ying Yang 1 (YY1) is a zinc finger protein that is strongly
enriched at interaction sites between NPC-specific genes
and enhancers [50]. YY1 is critical for neuronal differen-
tiation [56] and in humans, haploinsufficiency of YY1
results in loss of H3K27ac at enhancers, transcriptional
dysregulation and intellectual disability [57]. Knockdown
of YY1 in NPCs reduced the interaction frequency
between the YY1-bound genes Sox2, Klf4, and Zfp462
and their enhancers, concomitantly inhibiting theirCurrent Opinion in Neurobiology 2019, 59:16–25 expression levels [50]. Interestingly, another study has
suggested that YY1 regulates enhancer–promoter looping
not only in NPCs but also in pluripotent cells and in other
differentiated cell types [49].
The lineage-specific factors that help to organize genome
structure also undergo substantial changes during neuronal
differentiation (Figure 1c). In ESCs, contacts occur between
sites bound by Polycomb, and sites bound by pluripotency-
specific transcription factors, such as Nanog. During neuro-
nal differentiation, expression levels, chromatin occupancy
and the contacts mediated by these factors all decrease. In
NPCs, contacts occur between regions bound by the tran-
scription factor Pax6 [23], which is a master regulator of the
NPC state. NeuroD2 and Tbr1 were also found at contact
sites during neuronal development, with interactions
increasing during differentiation to peak in mature CNs.
Similarly, in olfactory neurons, the transcription factor Lhx2
and its cofactor Ldb1 were necessary for the interaction of
olfactory receptor genes with each other and with enhancers
[48]. Taken together, these findings indicate that dynamic
organization of chromatin contacts around developmental
stage-specific transcription factors within TAD boundaries
significantly affects gene expression.
Consequences of alterations in enhancer–promoter
looping
Disruption of enhancer–promoter loops (Figure 3c) has
been linked to a number of neurological diseases. For
example, single nucleotide polymorphisms (SNPs) have
been found at sites that physically interact with genes
implicated in schizophrenia [24,58]. SNPs that may dis-
rupt chromatin looping have been identified at contact sites
of the risk locus CACNA1C [58], the anti-psychotic drug
target gene DRD2, several acetylcholine receptors, and
genes involved in excitatory synaptic transmission [24].
Although it is not clear whether all of these mutations
interfere with expression of their partnered schizophre-
nia-related gene, at least in the case of FOXG1 a mutation in
a region found to loop to the promoter abrogated FOXG1
expression [24]. Similarly, SNPs associated with four
neurodegenerative disorders (Frontotemporal lobar degen-
eration, Alzheimer’s disease, Parkinson’s disease, and
Amyotrophic lateral sclerosis) significantly overlap with
CTCF binding sites [59]. SNPs at interaction sites can
stimulate inappropriate expression as well as abrogate
expression. OneSNP associated with Frontotemporal lobar
degeneration was found to promote CTCF-mediated loop-
ing from cis-regulatory elements to the TMEM106B pro-
moter, increasing its expression [59]. Disrupted looping in
the absence of specific mutations has also been found in
neurological disease, for example at the GAD1 locus, which
encodes the enzyme that synthesizes the neurotransmitter
GABA, in schizophrenia [60].
Finally, it is tempting to speculate that changes in geno-
mic architecture could represent an early pathogenicwww.sciencedirect.com
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eases, thereby suggesting that neuropsychological disor-
ders that manifest later in life may be rooted into genome
conformational changes that occurred at earlier develop-
mental stages.
Conclusions
It is becoming increasingly clear that genome topology
and radial nuclear location affect genome organization
and spatiotemporal activation of gene expression in the
nervous system. There are many factors that can influ-
ence transcription, including epigenetic modifications of
DNA and histones, nucleosome remodeling, non-coding
RNAs and region relocation to specific nuclear compart-
ments. Many of these mechanisms intercalate with
genome topology and exert changes through it. Folding
of the genome into TAD and sub-TAD compartments
plays a key role in the regulation of gene expression as
this, among other events, limits the contacts between
genes and their enhancers and co-regulated genes. Of
note, genome ‘contacts’ are highly dynamic events that
indicate proximity of sequences in 3D space and fre-
quency of interaction, rather than fixed structures. Impor-
tantly, radial location of genes within the nuclear space
affects both the chromatin environment and promoter
accessibility to other genes and regulatory regions. Many
neurological disorders can arise as a direct result of
dysregulation of genome architecture, both through
mutations of genes encoding proteins that have a crucial
role in establishing or maintaining appropriate chromatin
structure, or through mutations in the DNA sequences at
critical contact points (Figure 3). Importantly, changes in
genome topology may confer transcriptional priming,
rather than activation, and potentially provide the biolog-
ical basis for predisposition to neuropsychiatric disorders.
Although the contribution of genome architecture to the
pathogenesis of neurodevelopmental disorders awaits
further investigation, technologies aimed at modifying
chromatin structure may help restore appropriate gene
expression in diseased neurons.
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